iRhythm Technologies, Inc. (IRTC)’s Stock Is Buy After Achieving 52-Week High

June 14, 2018 - By Duane Lopez

The stock of iRhythm Technologies, Inc. (NASDAQ:IRTC) hit a new 52-week high and has $86.89 target or 7.00 % above today’s $81.21 share price. The 7 months bullish chart indicates low risk for the $1.92B company. The 1-year high was reported on Jun, 14 by If the $86.89 price target is reached, the company will be worth $134.12 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.26% or $0.215 during the last trading session, reaching $81.205. About 175,806 shares traded. iRhythm Technologies, Inc. (NASDAQ:IRTC) has risen 103.18% since June 14, 2017 and is uptrending. It has outperformed by 90.61% the S&P500.

Analysts await iRhythm Technologies, Inc. (NASDAQ:IRTC) to report earnings on August, 1. They expect $-0.41 EPS, down 41.38 % or $0.12 from last year’s $-0.29 per share. After $-0.47 actual EPS reported by iRhythm Technologies, Inc. for the previous quarter, Wall Street now forecasts -12.77 % EPS growth.

More recent iRhythm Technologies, Inc. (NASDAQ:IRTC) news were published by: which released: “JAMA Cardiology publishes RHYTHM Study Revealing Link Between Total AF Burden and Stroke Risk” on May 16, 2018. Also published the news titled: “Real-world study supports value proposition of iRhythm’s Zio” on May 16, 2018.‘s news article titled: “Investor Expectations to Drive Momentum within Core-Mark Holding, SSR Mining, iRhythm Technologies, Magic …” with publication date: June 06, 2018 was also an interesting one.

iRhythm Technologies, Inc., a digital healthcare company, focuses on the provision of ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias in the United States. The company has market cap of $1.92 billion. It offers ZIO Service, a platform that provides wearable biosensor with cloud data analytics that distill data from heartbeats into clinically actionable information. It currently has negative earnings.

iRhythm Technologies, Inc. (NASDAQ:IRTC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: